Connect with us
European Gaming Congress 2024

Artificial Intelligence

Medical Laser Market to Surpass USD 8.76 Billion by 2028 as Eye Disorders and Cosmetic Procedures Rises

Published

on

Westford USA, Jan. 12, 2023 (GLOBE NEWSWIRE) — Some promising factors responsible for the rapid growth of the medical laser market include the rising demand for these lasers to treat various illnesses and the increasing desire for non-invasive therapies. Medical laser technology generates a focused beam of light with a specified wavelength. A medical laser is a non-invasive, powerful light source that helps treat tissue and promotes quick, uneventful healing. Additionally, one of the major drivers propelling the market is people’s increasing knowledge of aesthetic procedures, including body sculpting, acne prevention, and dermal resurfacing. The rise of medical tourism across several locations is projected to offer industry participants significant growth opportunities.

According to SkyQuest’s research, the U.S. performs about 700,000 procedures annually. While in the U.K., around 330,000 cataract surgeries are carried out annually. According to the World Health Organization’s (WHO) official report, published in October 2021, roughly 2.2 billion individuals worldwide suffer from near- or far-sightedness, with about 1 billion of these instances being preventable or unaddressed. Additionally, the WHO estimates that approximately 17.5 million chronic cardiovascular disorders requiring surgical follow-up are recorded each year involving these individuals. Such statistic shows that the medical laser market is likely to witness significant traction to deal with the rising prevalence of eye-related diseases.

Cosmetic Laser Treatment Segment to Register Fastest Growth Rate owing to Increased Cost-Effectiveness

North America clearly dominates the market with a revenue share of more than 50%. This dominance is anticipated to grow further due to the widespread use of cosmetic lift-ups and rising patient healthcare spending. According to SkyQuest’s market research, 50 to 55 million Americans experience acne issues each year, making it a prevalent condition. Machine learning and artificial intelligence provide new and more effective solutions to the aging and expanding global population. According to estimates, China spends 6% of its GDP on healthcare, and the country’s market for medical equipment has increased by double digits during the last three decades.

A.I. integration into cosmetic laser treatment can help reduce risks and side effects, improve precision for better results, eliminate the possibility of human mistakes, simplify therapy for doctors, and create a more cost-effective strategy for patients and doctors. The rising use of cosmetic operations drives the expansion of the medical laser market, advancements in laser technology, increased attention to physical appearance among both men and women, and high disposable income in developing nations.

Advertisement
Stake.com

The market segmentation and size information by categories, product types, applications, and regions are covered in the research report on the medical laser market. In addition, in-depth analyses of important topics, trends, drivers, difficulties, and business scope are also included in the research. The research thoroughly examines the geographic outlook to clarify the regional context and highlight the potential and unexplored opportunities in the target market.

Get a sample copy of this report:

https://skyquestt.com/sample-request/medical-laser-market

Growing Demand for Minimally Invasive Surgical Procedures to Boost Medical Laser Market

The minimally invasive surgery industry witnessed a 4.6% year-over-year gain. The global minimally invasive surgery market is projected to grow at a CAGR of 5.4% from 2022 to 2028 and reach a value of US$ 8.5 billion. The rising demand provides significant potential for the medical laser market’s growth for minimally invasive surgical procedures in the realms of ophthalmic laser surgery and other treatments involving sensory organs. Growth opportunities are increased by the emergence of numerous multi-specialty hospitals offering various services along with reimbursement options. Reduced patient discomfort levels have also proven to be a substantial commercial opportunity for medical lasers.

Advertisement
Stake.com

The crucial information, which includes facts, figures, and projections, is gathered from various industry sources. The report provides information on the market’s current opportunities and offers predictions for new market developments that may provide more lucrative future opportunities. The study does a great job of exposing significant potential in various regional markets worldwide with analysis accuracy that meets industry standards and strong data quality.

Browse summary of the report and Complete Table of Contents (ToC):

https://skyquestt.com/report/medical-laser-market

Key Developments in Medical Laser Market

  • AdValue Photonics, Inc., a top producer of cutting-edge fiber lasers for the materials processing, scientific, LIDAR, and medical markets, recently delivered a high-power, single-frequency 308 nm U.V. laser to NASA Goddard Space Flight Center for use in atmospheric investigations.
  • Keranova, a firm specializing in developing surgical ophthalmic equipment, has announced the completion of regulatory and clinical tests for their robotic laser technology, FemtoMatrix®. With these extraordinary and unparalleled results, the company will now submit an application for C.E. marking for this newly developed surgical equipment in cataract surgery.
  • FibroLux, a laser-based therapy developed by Multi Radiance Medical, became the Food and Drug Administration’s (FDA) first “photoceutical” device approved to help people with fibromyalgia manage pain. Patients with fibromyalgia are frequently hypersensitive to pain that would not usually affect most people, and they may endure significant exhaustion and memory issues.
  • LASEROPTEK Co., Ltd., a leading manufacturer of lasers for medical aesthetic and dermatological reasons, has announced the signing of a multi-year, nationwide distribution deal with Monarch Lasers. The agreement covers sales, marketing, and clinical education for LASEROPTEK’s line of FDA-cleared laser systems for medical aesthetic reasons in the United States.  

The research demonstrates that it is a trustworthy source for market participants seeking a competitive advantage over their competitors and achieving long-term success in the target market. The facts, data, and findings included in the research report are authentic due to the contributions of reliable sources. In addition to this, the market report also covers crucial case studies of leading market players who are performing well in the industry. Such insights will help market participants plan their future strategies.

Speak to Analyst for your custom requirements:

Advertisement
Stake.com

https://skyquestt.com/speak-with-analyst/medical-laser-market

Prominent Players in the Medical Laser Market

  • IRIDEX Corporation
  • Ellex Medical Lasers Ltd.
  • Lumenis Ltd.
  • Novartis AG
  • CryoLife, Inc.
  • Biolase Inc.
  • Koninklijke Philips N.V.
  • Bausch & Lomb Holdings, Inc.
  • Boston Scientific Corporation
  • Quantel laser
  • Syneron Medical Ltd.
  • Topcon Corporation
  • Nidek CO., LTD.
  • SharpLight Technologies
  • DEKA M.E.L.A. S.r.l.
  • Alma Lasers
  • Sciton, Inc.

Related Reports in SkyQuest’s Library:

Global Healthcare Data Interchange (EDI) Market

Global Oncology Ablation Market

Global Virtual Patient Simulation Market

Advertisement
Stake.com

U.S. Healthcare Staffing Market

Global E-Prescription Market

About Us:

SkyQuest Technology is leading growth consulting firm providing market intelligence, commercialization and technology services. It has 450+ happy clients globally.

Address:

Advertisement
Stake.com

1 Apache Way, Westford, Massachusetts 01886

Phone:

USA (+1) 617-230-0741

Email: [email protected]

LinkedIn Facebook Twitter

Advertisement
Stake.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Transforming Healthcare with AI: Yidu Tech’s Gong Rujing at Summer Davos

Published

on

transforming-healthcare-with-ai:-yidu-tech’s-gong-rujing-at-summer-davos

DALIAN, China, July 1, 2024 /PRNewswire/ — “AI in healthcare is extremely challenging. For companies, it requires not only solving scientific problems but also understanding AI technology and respecting the complexity of the healthcare industry.” At the 15th Annual Meeting of the New Champions, also known as Summer Davos, Ms. Gong Rujing (Yingying), Chairwoman and Founder of Yidu Tech, was invited as a distinguished representative of the healthcare technology sector. She shared her unique insights into the future of AI in healthcare during the thematic dialogue on “Healthcare Analytics, Not Moving Fast Enough.”

This year marks the 10th anniversary of Yidu Tech and Ms. Gong Rujing’s decade-long dedication to the healthcare industry. From the inception of her entrepreneurial journey 10 years ago, she has been driven by the mission to leverage the power of technology to deliver precise healthcare to every individual.
Ms. Gong described the past decade as a journey filled with miracles and achievements. During this period, Yidu Tech has progressively established close collaborations with key stakeholders in the healthcare industry, including government agencies, hospitals, pharmaceutical companies, insurance firms, experts, and clinicians. As of March 31, 2024, Yidu Tech’s “AI Medical Brain” YiduCore has been authorized to process and analyze over 5 billion medical records, covering more than 2,500 hospitals.
In AI-powered clinical research, Yidu Tech has supported researchers and clinicians in producing over 240 high-level papers, accelerating the application of research outcomes. Additionally, Yidu Tech provides clinical trial services to globally renowned pharmaceutical companies, helping them optimize trial processes, reduce costs, and bring new drugs to market more swiftly, ultimately benefiting patients. In healthcare management, Yidu Tech’s AI technology plays a crucial role by analyzing vast amounts of medical data to provide comprehensive decision support to healthcare administrators, helping them optimize resource allocation and improve service efficiency.
“We are now entering a new era of AI technology.” The development of large language model technologies has opened up new possibilities across various industries. Yidu Tech has independently developed a large language model specific to the medical field and is advancing its application across the entire healthcare industry chain. The goal is to promote further progress and innovation through new AI technologies. However, Ms. Gong also emphasized that the healthcare industry is professional, complex, and sensitive, and the application of new technologies must address challenges such as data security, privacy protection, and ethics.
“Data security and privacy protection are fundamental to the development of AI technology and medical big data technology. We must ensure that all stakeholders are satisfied with compliance, security, accessibility, and privacy protection.”
“AI technology still has a long way to go.” She called on policymakers, healthcare institutions, and technology companies to work together to realize the immense potential of healthcare data. Ms. Gong highlighted that building trust is key, and enhancing data operability is essential to fully unleash the power of data. “It’s not just about better data quality; it’s about a better future for health.”

View original content:https://www.prnewswire.co.uk/news-releases/transforming-healthcare-with-ai-yidu-techs-gong-rujing-at-summer-davos-302186561.html

Continue Reading

Artificial Intelligence

Yidu Tech’s FY2024 results: existing business achieves first full-year profit on adjusted EBITDA

Published

on

yidu-tech’s-fy2024-results:-existing-business-achieves-first-full-year-profit-on-adjusted-ebitda

HONG KONG, July 1, 2024 /PRNewswire/ — On June 27, 2024, Yidu Tech Inc. (the ”Company” or ”Yidu Tech”) (2158.HK), a leader in China’s AI medical industry, announced its results for the 2024 fiscal year. During the reporting period, the Company recorded revenue of RMB 807.1 million. Gross profit margin in FY2024 increased to 42.1% from 34.1% in FY2023, representing an increase of 8 percentage points, hitting a record high. Adjusted net loss narrowed from RMB 448.7 million in FY2023 to RMB158.1 million, down 64.8% year-on-year. The management of Yidu Tech said at the annual results conference the next day that excluding strategic investments in proprietary large language model, non-cash items, and non-operating items, the adjusted EBITDA for our current business has achieved profit, moving from a RMB 327 million loss to a profit of RMB 31.1 million for the first time this fiscal year.

Management added that as of market close on June 27, the Company’s P/B ratio has decreased to 1.06. Not including the valuation of its domestic and international businesses, its market value is still lower than its fund reserves on hand. As such, management believes that the Company’s share price is still severely undervalued. Notably, renowned sovereign fund BIA has continually increased its shareholding of Yidu Tech by 21.50% over the past two months. The management is confident in the Company’s long-term growth potential and hopes to continually create innovative technologies and increase returns to its shareholders.
In FY2024, Yidu Tech focused on its core business, improving internal operating efficiency and earning quality. Among its earnings, revenue from its big data platform and solutions segment reached RMB 313.6 million, an increase of 41.4% year-on-year. Revenue from its life science solutions segment reached RMB 324.0 million, up 28.1% year-on-year and the gross margin increased by 14.6 percentage points to a historical high of 32.1%. Revenue from its health management platform and solutions segment reached RMB 169.5 million, and the gross profit margin of this segment was 58.1%, representing a year-on-year increase of 17.4 percentage points.
During the reporting period, the Company has continued the development and training of large language model in the medical vertical field based on 500 billion fine-trained Tokens, with model training for 6B, 13B, and 70B parameters completed.

View original content:https://www.prnewswire.co.uk/news-releases/yidu-techs-fy2024-results-existing-business-achieves-first-full-year-profit-on-adjusted-ebitda-302185986.html

Continue Reading

Artificial Intelligence

Lucinity’s AI Innovation Recognized at Microsoft’s Prestigious Global Partner Awards 2024

Published

on

lucinity’s-ai-innovation-recognized-at-microsoft’s-prestigious-global-partner-awards-2024

REYKJAVIK, Iceland, June 28, 2024 /PRNewswire/ — Lucinity has been recognized as a finalist in the AI Innovation category at the prestigious Microsoft Global Partner Awards 2024, recognizing its breakthrough AI solution and contribution to financial security through its collaboration with Microsoft. 

Lucinity beat more than 4,700 companies to be named a finalist at the annual Microsoft Global Partner Awards, which highlights Lucinity’s achievements as a Microsoft partner in optimizing business processes, improving customer experiences, and opening new pathways for digital transformation.
This achievement comes in addition to winning two prestigious awards at Microsoft Partner Awards 2024 last month, including Partner of the Year – Iceland, and the Sustainability and Social Impact award.
The accolade recognizes Lucinity’s significant advancements in AI for financial crime operations, particularly through their AI-powered copilot, Luci. This innovative solution utilizes Microsoft Azure OpenAI technology to integrate advanced generative AI into financial crime investigations and regulatory compliance, optimizing processes and saving significant time and resources for financial institutions.
The Lucinity platform streamlines compliance, provides instant insights, and reduces typical investigation times from three hours to just 30 minutes. The technology can also save financial institutions an estimated $100 million in productivity savings, as well as savings in training and recruitment.
Microsoft comments on Lucinity’s award recognition, saying “Financial crime profoundly impacts our global community, with far-reaching economic, security, and social implications. It can harm a country’s reputation and increase exposure to criminal activities, emphasizing the critical need for robust anti-money laundering initiatives and persistent vigilance. Lucinity, with their innovative AI solutions, has really tried to combat this huge global challenge. They use ‘Human AI’ to enhance financial crime prevention, combining AI with human expertise for efficient, user-friendly solutions. Additionally, Lucinity has developed a tool called Luci, an AI-powered copilot that helps transform financial crime prevention from a process that took hours to one that takes minutes.”
“Being recognized as a finalist at the Microsoft Global Partner Awards is  validation of our impactful collaboration with Microsoft in financial crime operations. Our partnership has been pivotal for our innovations, enabling us to use Azure OpenAI to bring tools like Luci to life and deliver impactful results for our clients,” says Guðmundur Kristjánsson, Founder & CEO of Lucinity.
Contact:Name: Celina PabloEmail: [email protected]: +354 792 4321
Logo: https://mma.prnewswire.com/media/2208676/4669079/Lucinity_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/lucinitys-ai-innovation-recognized-at-microsofts-prestigious-global-partner-awards-2024-302186091.html

Continue Reading

Trending